4//SEC Filing
Perry Nicole D 4
Accession 0001127602-21-019902
CIK 0001492422other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:04 PM ET
Size
8.1 KB
Accession
0001127602-21-019902
Insider Transaction Report
Form 4
Perry Nicole D
Vice President - Finance
Transactions
- Exercise/Conversion
Common Stock
2021-06-11$3.20/sh+1,000$3,200→ 5,847 total - Sale
Common Stock
2021-06-11$61.55/sh−1,000$61,555→ 4,847 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-11−1,000→ 34,161 totalExercise: $3.20Exp: 2025-06-02→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 3, 2015 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001657874
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:04 PM ET
- Size
- 8.1 KB